Steven Gould, MD, serves as the Consulting Director for Polsky Science Ventures and is responsible for leading the formation and launch of new science based ventures from University of Chicago faculty research. In this role, he advises faculty founders, engages the investor community, and works closely with leadership to develop future strategies for Polsky Science Ventures.

Steve is the Founder and Principal of The Gould Consulting Group, which provides advisory services to companies, universities and venture investors seeking to develop and capitalize on healthcare innovations in biotechnology and life sciences, devices, diagnostics, and healthcare IT. He is deeply engaged in the Chicago healthcare and entrepreneurial ecosystem. He is a founding member of the Board of Directors for MATTER; chair of the Advisory Board for Point B, a mentoring program formerly called Chicago Innovation Mentors (CIM); and a member of the Bioscience committee of WBC’s ChicagoNEXT. He has also previously served as a judge in the New Venture Challenge and has been an Entrepreneur-in-Residence at the Polsky Center.

He has in-depth experience raising capital for and investing in early stage companies in both clinical and scientific research in an academic environment, and as an executive for a publicly traded biotechnology company. As the scientific founder and former CEO of Northfield Laboratories, he led the company’s IPO and raised nearly $300 million in both public and private financings. Prior to Northfield, Steve was Chief of Surgery at Michael Reese Hospital and Medical Center and a professor of surgery at the University of Chicago and the University of Illinois at Chicago.

Steve received his BA from Williams College and his MD degree from Boston University School of Medicine. He completed his residency training in surgery at Yale and the University of Vermont, and a research fellowship at Michael Reese and the University of Chicago.